Zoetis, Inc. (ZTS)
77.29
+2.27
(+3.03%)
USD |
NYSE |
Aug 28, 16:00
77.51
+0.22
(+0.28%)
After-Hours: 16:40
Zoetis Cash from Operations (Quarterly) : 655.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 655.00M |
| March 31, 2026 | 401.00M |
| December 31, 2025 | 893.00M |
| September 30, 2025 | 938.00M |
| June 30, 2025 | 605.00M |
| March 31, 2025 | 515.00M |
| December 31, 2024 | 905.00M |
| September 30, 2024 | 951.00M |
| June 30, 2024 | 502.00M |
| March 31, 2024 | 595.00M |
| December 31, 2023 | 897.00M |
| September 30, 2023 | 724.00M |
| June 30, 2023 | 183.00M |
| March 31, 2023 | 549.00M |
| December 31, 2022 | 741.00M |
| September 30, 2022 | 526.00M |
| June 30, 2022 | 336.00M |
| March 31, 2022 | 309.00M |
| December 31, 2021 | 679.00M |
| September 30, 2021 | 653.00M |
| June 30, 2021 | 481.00M |
| March 31, 2021 | 400.00M |
| December 31, 2020 | 718.00M |
| September 30, 2020 | 562.00M |
| June 30, 2020 | 438.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 408.00M |
| December 31, 2019 | 582.00M |
| September 30, 2019 | 506.00M |
| June 30, 2019 | 318.00M |
| March 31, 2019 | 389.00M |
| December 31, 2018 | 584.00M |
| September 30, 2018 | 550.00M |
| June 30, 2018 | 267.00M |
| March 31, 2018 | 389.00M |
| December 31, 2017 | 608.00M |
| September 30, 2017 | 439.00M |
| June 30, 2017 | 180.00M |
| March 31, 2017 | 119.00M |
| December 31, 2016 | 286.00M |
| September 30, 2016 | 239.00M |
| June 30, 2016 | 137.00M |
| March 31, 2016 | 51.00M |
| December 31, 2015 | 278.00M |
| September 30, 2015 | 204.00M |
| June 30, 2015 | 122.00M |
| March 31, 2015 | 60.00M |
| December 31, 2014 | 387.00M |
| September 30, 2014 | 103.00M |
| June 30, 2014 | 159.00M |
| March 31, 2014 | -23.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Merck & Co., Inc. | 5.37B |
| Elanco Animal Health, Inc. | 277.00M |
| Boston Scientific Corp. | 1.474B |
| Pfizer Inc. | 835.00M |
| Phibro Animal Health Corp. | 24.09M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -300.00M |
| Cash from Financing (Quarterly) | -813.00M |
| Free Cash Flow | 2.366B |
| Free Cash Flow Per Share (Quarterly) | 1.288 |
| Free Cash Flow to Equity (Quarterly) | 538.00M |
| Free Cash Flow to Firm (Quarterly) | 591.46M |
| Free Cash Flow Yield | 7.11% |